TickerGuard
Buy Day today: Poor (44) Weak market breadth · no major macro event
ADRX

ADARx Pharmaceuticals, Inc.

Healthcare · Biotechnology

14.00$ -1.4% vs. previous close Closing price · As of: Nov 16, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ADRX
Line item Q4 25 Q1 26 Q2 26
100.0% 100.0% 100.0%
97.2% 97.1% 96.8%
13.1% 13.2% 12.8%
139.8% 146.8% 155.0%
6.0% 6.2% 7.5%
1.2% 1.4% 1.1%
-39.8% -46.8% -55.0%
-43.5% -50.4% -59.0%
– 21.2% 22.4%

Data as of: November 16, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?